News & media

Media information and facts

Media enquiry information

ACCF is a trusted advisor when it comes to HPV and the HPV vaccine, cervical health, cervical screening, and cervical cancer. You may also wish to contact us to connect with a cervical cancer patient or survivor from The Faces of Cervical Cancer where we share cervical cancer stories.

For media enquiries, please contact: 

Barb Tasker, CFO/Acting CEO, by email or phone 0474 147 477

Liz Ham, National Health Promotion Manager, by email or phone 0413 085 279.

Cervical cancer statistics

Cervical cancer: know the facts

Global Statistics 2023

  • Worldwide, cervical cancer is the fourth most common cancer affecting women (ranking fourth for both incidence and mortality).
  • In 2022, an estimated 604,000 women were diagnosed with cervical cancer worldwide, and over 342,000 women died from the disease.  
  • 90% of cases and deaths occur on low- and middle-income countries.1


Australian Statistics 2023

  • Cervical cancer was estimated to be the 13th most commonly diagnosed cancer among females in Australia in 2022.2
  • In 2021, 851 new cases of cervical cancer were diagnosed in women in Australia, and in 2020 209 women died from the disease.
  • Indigenous women are 2 times as likely to develop cervical cancer, and 3.8 times as likely to die from cervical cancer than non-Indigenous Australian women.
  • The five-year survival rate for women diagnosed with cervical cancer (measured between 2014-2018) is 74%4. In comparison, breast and prostate cancers have a five-year survival rate of 92% and 96% respectively.3
  • Over the 4 years 2018–2021, more than 4.2 million people aged 25–74 had a screening HPV test. This is estimated to be 62% of the eligible population. 4
  • Self-collection became an available screening option for women and people with a cervix in July 2022. Early 2023 figures indicate that self-collection accounts for up to 16% of cervical screenings. 
  • Among young people turning 15 in 2020, 80.5% of girls and 77.6% of boys were fully immunised against HPV.5
  • As of February 2023, only one dose of the HPV vaccine is needed. This is reduced from the 2 or 3 doses required previously.



1 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021:71:209–49. doi:10.3322/caac.21660

2 Australian Institute of Health and Welfare. Cancer data in Australia. Cat. no. CAN 122. [Accessed May 2022];

3 Australian Institute of Health and Welfare 2021. Cancer in Australia 2021. Cancer series no. 133. Cat. no. CAN 144. Canberra: AIHW

4 Australian Institute of Health and Welfare (2022) National Cervical Screening Program monitoring report 2022, catalogue number CAN 149, AIHW, Australian Government.

5 NCIRS (2021) National Centre for Immunisation Research and Surveillance Annual immunisation coverage report 2020

ACCF in the media

Credits National Cervical Screening Program

Credits ABC